FREE PROMEGA WEBINAR
Date : 20th October 2022
Time : 11 am (Indonesia)
Promega Webinar, In this webinar we will discuss historically MSI has been used to screen for Lynch syndrome, a dominant hereditary cancer propensity. In 2015, MS1 status has been rediscovered as a biomarker for immunotherapeutic respose, making MST status an increasingly relevant tool for genetics and immuno-oncology applications. In this webinar, we will discuss MS testing gold standards and compare the different methods that are currently being used for MS testing for mismatch repair deficient (dMMR) tumors. We will also discuss the clinical relevance of the MSI-H biomarker focusing on the pathological and epidemiological characteristics of MSI-H/dMMR tumors, and the role of MSI testing in Lynch syndrome screening, colorectal cancer patient prognosis, and immunotherapy treatment.
In this webinar, you will learn about the:
• Comparison between technologies to measure MSI to current gold-standard methods
• Clinical utility of the MS biomarker for Lynch syndrome screening and immunotherapy treatment
• Current clinical practice guidelines for MSI testing
Link Webinar : https://bit.ly/3MIBLTR
Media mikrobiologi adalah tulang punggung setiap laboratorium yang terlibat dalam studi atau aplikasi mikroorganisme. Fungsi…
Indolab Utama menghadirkan penawaran spesial akhir tahun!Dapatkan diskon hingga 50% untuk berbagai produk laboratorium pilihan.…
Seiring meningkatnya volume sampel, terutama dalam studi genetik skala besar (genomik) dan uji diagnostik klinis…
Indolab Utama baru saja menyelesaikan training seru Isolasi DNA menggunakan kit A1120 di UMMADA Cirebon!…
Kami bangga menjalin kolaborasi dengan RSUD Koja dalam meningkatkan layanan patologi mereka. Indolab Utama telah…
Fenomena bioluminescence, yaitu produksi cahaya oleh organisme hidup melalui reaksi kimia, telah lama memukau manusia…